Melissa Juniper, MS

Senior Director, Market Access and Outcomes Strategy
Contact
Melissa Juniper
Practice Area:
Therapeutic Expertise:
Office:
Headquarters - Research Triangle Park, North Carolina, USA

MS, Developmental Psychology
North Carolina State University, Raleigh, NC

BA, Psychology
Susquehanna University, Selinsgrove, PA

Certificate, Core Public Health Concepts
University of North Carolina at Chapel Hill, Chapel Hill, NC

Melissa Juniper, MS, is a Senior Director of Market Access and Outcomes Strategy at RTI-HS. In nearly 15 years with RTI-HS, Ms. Juniper has successfully led a number of large, multifaceted projects for leading pharmaceutical companies. She has focused on developing formulary submission dossiers, systematic literature reviews, and value dossiers. She has completed a certificate in Core Public Health Concepts at the University of North Carolina, as well as the Cochrane Interactive Learning Course on Conducting an Intervention Review, a training sponsored by the Academy of Managed Care Pharmacy (AMCP) on formulary submission dossier preparation, and an Expert Workshop at the Centre for Health Economics at the University of York. She offers knowledge in a variety of therapeutic areas, including cardiovascular disease (e.g., hypertension, atrial fibrillation, venous thromboembolism, acute coronary syndrome, atherosclerosis, hypercholesterolemia, and heart valve disease); hematology (hemophilia); diabetes (type 1 and type 2); oncology (e.g., multiple myeloma, chronic myeloid leukemia, acute lymphoblastic leukemia, soft tissue sarcoma, colorectal cancer, non–small cell lung cancer, hepatocellular carcinoma, renal cell carcinoma, gastric cancer, breast cancer, and glioblastoma multiforme); psychiatric disorders (e.g., bipolar disorder, schizophrenia, major depressive disorder, and generalized anxiety disorder); musculoskeletal and connective tissue disorders (e.g., osteoporosis, fibromyalgia, chronic low back pain, and rheumatoid arthritis); respiratory disorders (e.g., asthma and chronic obstructive pulmonary disease); and vaccines (influenza and herpes zoster).